
Nivolumab: Uses, Dosage, Side Effects & Warnings - Drugs.com
Jun 15, 2025 · Nivolumab can cause serious, sometimes life-threatening, side effects in many different parts of your body. Some side effects may need to be treated with other medicines, …
Nivolumab - NCI - National Cancer Institute
Nivolumab works by binding to and blocking the protein PD-1 on the surface of some cancer cells, which keeps cancer cells from suppressing the immune system. This allows the immune …
Nivolumab - Wikipedia
Nivolumab, sold under the brand name Opdivo, is an anti-cancer medication in the class of immune checkpoint inhibitors. It selectively binds and blocks the programmed death-1 (PD-1) …
Nivolumab (intravenous route) - Side effects & uses - Mayo Clinic
Nov 1, 2025 · Nivolumab injection is also used with ipilimumab as first-line treatment for malignant pleural mesothelioma (cancer that affects the inside lining of the lungs and chest wall) that …
Nivolumab (Opdivo) Advanced Treatment for Melanoma - MRA
As a systemic cancer treatment, immunotherapy is effective in fighting metastatic cancer, which has spread from the original tumor to other areas. Nivolumab (Opdivo) helps shrink tumors, …
Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in …
Sep 15, 2024 · Background Previous results from this trial showed longer overall survival after treatment with nivolumab plus ipilimumab or with nivolumab monotherapy than with ipilimumab …
Nivolumab - Chemocare
Nivolumab Injection What is this medication? NIVOLUMAB (nye VOL ue mab) treats some types of cancer. It works by helping your immune system slow or stop the spread of cancer cells. It is …
Nivolumab (Opdivo®) - Macmillan Cancer Support
Nivolumab is also called Opdivo ®. It is a type of immunotherapy drug called a checkpoint inhibitor. Nivolumab can be given on its own or in combination with other drugs to treat many …
Ipilimumab and nivolumab - Cancer Research UK
Ipilimumab and nivolumab is a combination of immunotherapy treatments. It is a treatment for a number of different types of cancer. Find out more about the how you have them and the side …
Nivolumab plus ipilimumab versus nivolumab in microsatellite ...
Feb 1, 2025 · Nivolumab plus ipilimumab showed superior progression-free survival versus nivolumab across all treatment lines, with a manageable safety profile, in patients with …